Adam S. Grossman
Also at ADMA Biologics Inc
About
Adam S. Grossman is the President and Chief Executive Officer of ADMA, having joined the company as a director in 2007 and advancing through successive leadership roles. He served as President and Chief Operating Officer until his promotion to CEO in October 2011, and later assumed the Interim CFO role in April 2024.
With over 25 years of experience in the blood and plasma industry, his career encompasses significant expertise in launching products, managing clinical trials, and executing business development transactions. His professional journey includes pivotal roles at National Hospital Specialties, GenesisBPS, MedImmune, and the American Red Cross.
On a personal note, he is closely connected to ADMA through his family, being the son of Dr. Jerrold B. Grossman, a co-founder and Vice Chairman of the company. This background, coupled with a solid educational foundation from American University, has contributed to his comprehensive approach to leadership in the healthcare sector.
$ADMA Performance Under Adam S. Grossman
Past Roles
External Roles
Fixed Compensation
Performance Compensation
No information available on performance compensation for 2025